High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: Implications for pathogenesis

Virology

Volumn 305, Issue 2, 2003, Pages 330-338

  Wang, Wei Kung ^a,b   Chao, Day Yu ^a   Kao, Chuan Liang ^a   Wu, Han Chung ^b   Liu, Yung Ching ^c   Li, Chien Ming ^d   Lin, Shih Chung ^e   Ho, Shih Ting ^f   Huang, Jyh Hsiung ^g   King, Chwan Chuen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e KUO GENERAL HOSPITAL   (Taiwan)

^f TAINAN SIN LAU HOSPITAL   (Taiwan)

^g CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

Dengue virus; Immune complex; Pathogenesis; Quantification; RT PCR

Indexed keywords

VIRUS RNA;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; DENGUE; DENGUE VIRUS; DISEASE EXACERBATION; DISEASE MARKER; EPIDEMIC; FEMALE; FEVER; HUMAN; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION;

DENGUE VIRUS; DENGUE VIRUS GROUP;

EID: 0037455555     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1704     Document Type: Article

References (37)

1. Baba T. W., Jeong Y. S., Pennick D., Bronson R., Greene M. F., Ruprecht R. M. Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science. 267:1995;1820-1825.
2. Brandt W. E., McCown J. M., Gentry M. K., Russell P. K. Infection enhancement of dengue-2 virus in the U937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infect. Immunol. 36:1982;1036-1041.
3. Burke D. S., Nisalak A., Johnson D. E., Scott R. M. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 38:1988;172-180.
4. Falloon J., Eddy J., Wiener L., Pizzo P. A. Human immunodeficiency virus infection in children. J. Pediatr. 114:1989;1-30.
5. Freeman W. M., Walker S. J., Vrana K. E. Quantitative RT-PCR: Pitfalls and potential. Biotechniques. 26:1999;112-125.
6. Gentry M. K., Henchal E. A., McCown J. M., Brandt W. E., Dalrymple J. M. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am. J. Trop. Med. Hyg. 31:1982;548-555.
7. Green S., Vaughn D. W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B. L., Kurane I., Rothman A. L., Ennis F. A. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 179:1999;755-762.
8. Gubler D. J., Reed D., Rosen L., Hitchcock J. C. J. Epidemiologic, clinical and virologic observations on dengue in the kingdom of Tonga. Am. J. Trop. Med. Hyg. 27:1978;581-589.
9. Gubler D. J., Suharyono W., Lubis I., Eram S., Saroso J. S. Epidemic dengue hemorrhagic fever in rural Indonesia. I. Virological and epidemiological studies. Am. J. Trop. Med. Hyg. 28:1979;701-710.
10. Gubler D. J., Suharyono W., Tan R., Abidin M., Sie A. Viremia in patients with naturally acquired dengue infection. Bull. WHO. 59:1981;623-630.
11. Gubler D. J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:1998;480-496.
12. Halstead S. B., O'Rourke E. J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature. 265:1977;739-741.
13. Halstead S. B. Pathogenesis of dengue: Challenges to molecular biology. Science. 239:1988;476-481.
14. Henchal E. A., Gentry M. K., McCown J. M., Brandt W. E. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am. J. Trop. Med. Hyg. 31:1982;830-836.
15. Huang Y. H., Liu C. C., Wang S. T., Lei H. Y., Liu H. S., Lin Y. S., Wu H. L., Yeh T. M. Activation of coagulation and fibrinolysis during dengue virus infection. J. Med. Virol. 63:2001;247-251.
16. Innis B. L. Dengue and dengue hemorrhagic fever. Porterfield J. S. Exotic viral infections - 1995. 1995;103-146 Chapman & Hall, London.
17. King C. C., Wu Y. C., Chao D. Y., Lin T. H., Chow L., Wang H. T., Ku C. C., Kao C. L., Hwang K. P., Lam S. K., Gubler D. J. Major epidemics of dengue in Taiwan in 1991-2000: Related to intensive virus activities in Asia. [Geneva, WHO]. Dengue Bull. 24:2000;1-10.
18. Lanciotti R. S., Calisher C. H., Gubler D. J., Chang G-J., Vorndam A. V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30:1992;545-551.
19. Leitmeyer K. C., Vaughn D. W., Watts D. M., Salas R., Villalobos I., de Chacon I.V., Ramos C., Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. J. Virol. 73:1999;4738-4747.
20. Libraty D. H., Endy T. P., Houng H. S., Green S., Kalayanarooj S., Suntayakorn S., Chansiriwongs W., Vaughn D. W., Nisalak A., Ennis F. A., Rothman A. L. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infection. J. Infect. Dis. 185:2002;1213-1221.
21. Monath T. P. Dengue, the risk to developed and developing countries. Proc. Natl. Acad. Sci. USA. 91:1994;2395-2400.
22. Murgue B., Roche C., Chungue E., Deparis X. Prospective study of the duration of magnitude of viremia in children hospitalized during the 1996-1997 dengue-2 outbreak in French Polynesia. J. Med. Virol. 60:2000;432-438.
23. Oldstone M. B. A. Immunotherapy for virus infection. Curr. Top. Microbiol. Immunol. 134:1987;211-229.
24. Osatomi K., Sumiyoshi H. Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology. 176:1990;643-647.
25. Piatak M., Saag M. S., Yang L. C., Clark S. J., Kappes J. C., Luk K. C., Hahn B. H., Shaw G. M., Lifson J. D. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science. 259:1993;1749-1754.
26. Rosen L. The emperor's new clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 26:1977;337-343.
27. Rothman A. L., Ennis F. A. Immunopathogenesis of dengue hemorrhagic fever. Virology. 257:1999;1-6.
28. Ruangjirachuporn W., Boonpucknavig S., Nimmanitya S. Circulating immune complexes in serum from patients with dengue hemorrhagic fever. Clin. Exp. Immunol. 36:1979;46-53.
29. Scott R. M., Nisalak A., Cheamudon U., Seridhoranakul S., Nimmannitya S. Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever. J. Infect. Dis. 141:1980;1-6.
30. Shu P. Y., Chen L. K., Chang S. F., Yueh Y. Y., Chow L., Chien L. J., Chin C., Lin T. H., Huang J. H. Dengue NS1-specific antibody responses: Isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J. Med. Virol. 62:2000;224-232.
31. Sudiro T. M., Zivny J., Ishiko H., Green S., Vaughn D. W., Kalayanarooj S., Nisalak A., Norman J. E., Ennis F. A., Rothman A. L. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitive reverse transcription-polymerase chain reaction. J. Med. Virol. 60:2001;29-34.
32. Thein S., Aung M. M., Shwe T. N., Aye M., Zaw A., Aye K., Aye K. M., Aaskov J. Risk factors in dengue shock syndrome. Am. J. Trop. Med. Hyg. 56:1997;566-572.
33. Vaughn D. W., Green S., Kalayanarooj S., Innis B. L., Nimmannitya S., Suntayakorn S., Rothman A. L., Ennis F. A., Nisalak A. Dengue in the early febrile phase: Viremia and antibody responses. J. Infect. Dis. 176:1997;322-330.
34. Vaughn D. W., Nisalak A., Solomon T., Kalayanarooj S., Dung N. M., Kneen R., Cuzzubbo A., Devine P. L. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am. J. Trop. Med. Hyg. 60:1999;693-698.
35. Vaughn D. W., Green S., Kalayanarooj S., Innis B. L., Nimmannitya S., Suntayakorn S., Endy T. P., Raengsakulrach B., Rothman A. L., Ennis F. A., Nisalak A. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 181:2000;2-9.
36. Wang W. K., Lee C. N., Kao C. L., Lin Y. L., King C. C. Quantitative competitive reverse transcription-PCR for quantification of dengue virus RNA. J. Clin. Microbiol. 38:2000;3306-3310.
37. Dengue Hemorrhagic Fever, Diagnosis, Treatment, and Control. 1997;World Health Organization, Geneva.